Natalia Timofeeva

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

|Apr 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Varsha Gandhi, Shady Tantawy, Burcu Aslan

|Feb 14, 2025
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice.

Natalia Timofeeva, Nitin Jain, Varsha Gandhi

|Apr 30, 2021
Ibrutinib combinations in CLL therapy: scientific rationale and clinical results.

Natalia Timofeeva, Varsha Gandhi

Pageof 1

Frequent Collaborators

5 joint publications

Varsha Gandhi

2 joint publications

Ganiraju Manyam

2 joint publications

Keyur Patel

2 joint publications

Sai Prasad Desikan